This site uses cookies to provide you with a better browsing experience. More information can be found on the Frontier Medicines
Privacy Policy
page.
Accept
Home
About
Team
Investors
Science
Chemoproteomics
Platform
Partnerships
News & Media
Press Releases
Presentations
Media Coverage
Media Center
Careers
Contact
Terms of Use
Privacy Policy
About
Team
Investors
Science
Chemoproteomics
Platform
Partnerships
News & Media
Press Releases
Presentations
Media Coverage
Media Center
Careers
AbbVie Eyes Cancer, Immunology in Latest Protein Degradation Pact, Handing Frontier Medicines $55M Upfront
December 2, 2020
BACK
